Notice for hemin (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
hemin
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
Indicated for the treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, porphyria variegate, hereditary corproporphyria and delta-aminolevulinic acid dehydratase porphyria)
Therapeutic area
Haematology